Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China · Delayed Price · Currency is CNY 42.00
+0.44 (1.06%)
Jul 13, 2026, 3:00 PM CST
SHA:688050 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, SHA:688050 stock has a consensus rating of "Buy" and an average price target of ¥59.16. The average 1-year stock price forecast is 40.86% higher than the current stock price, while the lowest is ¥40.00 (-4.76%) and the highest is ¥70.65 (+68.21%).
Price Target: ¥59.16 (+40.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:688050 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 6 | 6 |
Financial Forecast
Revenue This Year
1.83B
from 1.48B
Increased by 23.17%
Revenue Next Year
2.16B
from 1.83B
Increased by 18.36%
EPS This Year
1.81
from 1.33
Increased by 36.09%
EPS Next Year
2.18
from 1.81
Increased by 20.44%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9B | ||
| Avg | 1.8B | ||
| Low | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.5% | ||
| Avg | 23.2% | ||
| Low | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.81 | ||
| Avg | 1.81 | ||
| Low | 1.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 36.1% | ||
| Avg | 36.1% | ||
| Low | 36.1% |